Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
AIDS Res Hum Retroviruses ; 17(16): 1481-8, 2001 Nov 01.
Article in English | MEDLINE | ID: mdl-11709092

ABSTRACT

c-Myb is expressed in proliferating T cells. Fifteen c-Myb-binding sites can be identified in the HIV-1 long terminal repeat (LTR), suggesting that c-Myb may regulate HIV-1 gene expression and virus replication. Increasing the cellular levels of c-Myb by transient transfection of CEM cells resulted in a 10- to 20-fold activation of HIV-1 LTR-driven gene expression and mutation of one high-affinity Myb-binding site within the LTR reduced this activation by 60 to 70%. Conversely, inhibition of c-Myb expression in MT-2 cells by treatment with c-myb antisense oligonucleotides decreased HIV-1 replication by 85%, as measured by reverse transcriptase activity and cytopathic effects. The effect of c-myb antisense oligonucleotides on HIV-1 gene expression and virus particle production appeared to be independent of cell proliferation, but dependent on the presence of c-Myb activity mediated through the HIV-1 LTR. These data show that c-myb expression affects HIV-1 replication in CD4(+) T cells.


Subject(s)
Gene Expression Regulation, Viral , HIV-1/genetics , Proto-Oncogene Proteins c-myb/pharmacology , Transcriptional Activation , Virus Replication/drug effects , CD4-Positive T-Lymphocytes/virology , Cell Line , DNA, Viral/metabolism , HIV Long Terminal Repeat/genetics , HIV Long Terminal Repeat/physiology , HIV-1/physiology , Humans , Proto-Oncogene Proteins c-myb/metabolism
2.
J Virol ; 74(22): 10581-8, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11044102

ABSTRACT

Long-term survivors (LTS) of human immunodeficiency virus type 1 (HIV-1) infection provide an opportunity to investigate both viral and host factors that influence the rate of disease progression. We have identified three HIV-1-infected individuals in Australia who have been infected for over 11 years with viruses that contain deletions in the nef and nef-long terminal repeat (nef/LTR) overlap regions. These viruses differ from each other and from other nef-defective strains of HIV-1 previously identified in Australia. One individual, LTS 3, is infected with a virus containing a nef gene with a deletion of 29 bp from the nef/LTR overlap region, resulting in a truncated Nef open reading frame. In addition to the Nef defect, only viruses containing truncated Vif open reading frames of 37 or 69 amino acids could be detected in peripheral blood mononuclear cells isolated from this patient. LTS 3 had a viral load of less than 20 copies of RNA/ml of plasma. The other two long-term survivors, LTS 9 and LTS 11, had loads of less than 200 copies of RNA/ml of plasma and are infected with viruses with larger deletions in both the nef alone and nef/LTR overlap regions. These viruses contain wild-type vif, vpu, and vpr accessory genes. All three strains of virus had envelope sequences characteristic of macrophagetropic viruses. These findings further indicate the reduced pathogenic potential of nef-defective viruses.


Subject(s)
Gene Deletion , Genes, nef , HIV Infections/virology , HIV Long-Term Survivors , HIV-1/genetics , Terminal Repeat Sequences/genetics , Amino Acid Sequence , Disease Progression , Gene Products, nef/genetics , Gene Products, nef/physiology , Gene Products, vif/chemistry , Genes, vif , HIV Envelope Protein gp120/genetics , HIV Infections/physiopathology , HIV-1/classification , HIV-1/physiology , Humans , Macrophages/virology , Molecular Sequence Data , Peptide Fragments/genetics , Sequence Analysis, DNA , nef Gene Products, Human Immunodeficiency Virus , vif Gene Products, Human Immunodeficiency Virus
3.
N Engl J Med ; 340(22): 1715-22, 1999 Jun 03.
Article in English | MEDLINE | ID: mdl-10352163

ABSTRACT

BACKGROUND AND METHODS: The Sydney Blood Bank Cohort consists of a blood donor and eight transfusion recipients who were infected before 1985 with a strain of human immunodeficiency virus type 1 (HIV-1) with a deletion in the region in which the nef gene and the long terminal repeat overlap. Two recipients have died since 1994, at 77 and 83 years of age, of causes unrelated to HIV infection; one other recipient, who had systemic lupus erythematosus, died in 1987 at 22 years of age of causes possibly related to HIV. We present longitudinal immunologic and virologic data on the six surviving members and one deceased member of this cohort through September 30, 1998. RESULTS: The five surviving recipients remain asymptomatic 14 to 18 years after HIV-1 infection without any antiretroviral therapy; however, the donor commenced therapy in February 1999. In three recipients plasma concentrations of HIV-1 RNA are undetectable (<200 copies per milliliter), and in two of these three the CD4 lymphocyte counts have declined by 9 and 30 cells per cubic millimeter per year (P=0.3 and P=0.5, respectively). The donor and two other recipients have median plasma concentrations of HIV-1 RNA of 645 to 2850 copies per milliliter; the concentration has increased in the donor (P<0.001). The CD4 lymphocyte counts in these three cohort members have declined by 16 to 73 cells per cubic millimeter per year (P<0.001). In the recipient who died after 12 years of infection, the median plasma concentration of HIV-1 RNA was 1400 copies per milliliter, with a decline in CD4 lymphocyte counts of 17 cells per cubic millimeter per year (P=0.2). CONCLUSIONS: After prolonged infection with this attenuated strain of HIV-1, there is evidence of immunologic damage in three of the four subjects with detectable plasma HIV-1 RNA. The CD4 lymphocyte counts appear to be stable in the three subjects in whom plasma HIV-1 RNA remains undetectable.


Subject(s)
Genes, nef , HIV Infections/immunology , HIV Infections/virology , HIV-1/classification , HIV-1/genetics , Adult , Aged , Aged, 80 and over , CD4 Lymphocyte Count/drug effects , Disease Progression , Female , HIV Infections/mortality , HIV Long Terminal Repeat/genetics , HIV-1/isolation & purification , Humans , Longitudinal Studies , Male , Middle Aged , Mutation , RNA, Viral/blood , Viral Load
SELECTION OF CITATIONS
SEARCH DETAIL
...